Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Biological Chemistry
|
October 26, 2016
Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity
An Li, Shanzhong Gong, Kenneth A Johnson
Cell Reports
|
January 11, 2018
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Shanzhong Gong, Helen Hong Yu, Kenneth A Johnson, et al.
Methods in Enzymology
|
January 30, 2019
Kinetic characterization of Cas9 enzymes
Mu-Sen Liu, Shanzhong Gong, Helen-Hong Yu, et al.
The Journal of Biological Chemistry
|
December 14, 2020
Kinetic and thermodynamic analysis defines roles for two metal ions in DNA polymerase specificity and catalysis
Shanzhong Gong, Serdal Kirmizialtin, Adrienne Chang, et al.
Nature Communications
|
July 19, 2020
Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA
Mu-Sen Liu, Shanzhong Gong, Helen-Hong Yu, et al.
Chemical Communications (Cambridge, England)
|
May 11, 2018
A new probe for detecting zinc-bound carbonic anhydrase in cell lysates and cells
Radhika Mehta, Munaum H Qureshi, Meredith K Purchal, et al.
Plos Pathogens
|
March 6, 2013
Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection
Chuanmin Cheng, Arathy D S Nair, Vijaya V Indukuri, et al.
Journal of Medicinal Chemistry
|
March 4, 2025
Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion
Kevin M Cottrell, Kimberly J Briggs, Alice Tsai, et al.
Journal of Medicinal Chemistry
|
April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor
Scott Throner, Tianshu Feng, Jannik N Andersen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Biological Chemistry
|
October 26, 2016
Rate-limiting Pyrophosphate Release by HIV Reverse Transcriptase Improves Fidelity
An Li, Shanzhong Gong, Kenneth A Johnson
Cell Reports
|
January 11, 2018
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Shanzhong Gong, Helen Hong Yu, Kenneth A Johnson, et al.
Methods in Enzymology
|
January 30, 2019
Kinetic characterization of Cas9 enzymes
Mu-Sen Liu, Shanzhong Gong, Helen-Hong Yu, et al.
The Journal of Biological Chemistry
|
December 14, 2020
Kinetic and thermodynamic analysis defines roles for two metal ions in DNA polymerase specificity and catalysis
Shanzhong Gong, Serdal Kirmizialtin, Adrienne Chang, et al.
Nature Communications
|
July 19, 2020
Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA
Mu-Sen Liu, Shanzhong Gong, Helen-Hong Yu, et al.
Chemical Communications (Cambridge, England)
|
May 11, 2018
A new probe for detecting zinc-bound carbonic anhydrase in cell lysates and cells
Radhika Mehta, Munaum H Qureshi, Meredith K Purchal, et al.
Plos Pathogens
|
March 6, 2013
Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection
Chuanmin Cheng, Arathy D S Nair, Vijaya V Indukuri, et al.
Journal of Medicinal Chemistry
|
March 4, 2025
Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion
Kevin M Cottrell, Kimberly J Briggs, Alice Tsai, et al.
Journal of Medicinal Chemistry
|
April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers
Kevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor
Scott Throner, Tianshu Feng, Jannik N Andersen, et al.
Page
of 2